1. Aheget, H., et al., Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases. Cancers (Basel), 2020. 13(1).
2. Lee, Y., S. El Andaloussi, and M.J. Wood, Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet, 2012. 21(R1): p. R125-34.
3. Konoshenko, M.Y., et al., Isolation of Extracellular Vesicles: General Methodologies and Latest Trends. Biomed Res Int, 2018. 2018: p. 8545347.
4. Livshits, M.A., et al., Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. Sci Rep, 2015. 5: p. 17319.
5. Gamez-Valero, A., et al., Size-Exclusion Chromatography-based isolation minimally alters Extracellular Vesicles' characteristics compared to precipitating agents. Sci Rep, 2016. 6: p. 33641.
6. Zarovni, N., et al., Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods, 2015. 87: p. 46-58.
7. Yang, B., et al., Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal Bioanal Chem, 2011. 399(2): p. 541-57.
8. Powell, A.K., et al., Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches. Glycobiology, 2004. 14(4): p. 17R-30R.
9. Couch, Y., et al., A brief history of nearly EV-erything - The rise and rise of extracellular vesicles. J Extracell Vesicles, 2021. 10(14): p. e12144.
10. Yokoi, A. and T. Ochiya, Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology. Semin Cancer Biol, 2021. 74: p. 79-91.
11. Liu, Y.J. and C. Wang, A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Commun Signal, 2023. 21(1): p. 77.
12. Valadi, H., et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 2007. 9(6): p. 654-659.
13. van der Meel, R., et al., Extracellular vesicles as drug delivery systems: Lessons from the liposome field. Journal of Controlled Release, 2014. 195: p. 72-85.
14. Barenholz, Y., Doxil® — The first FDA-approved nano-drug: Lessons learned. Journal of Controlled Release, 2012. 160(2): p. 117-134.
15. Laouini, A., et al., Preparation, Characterization and Applications of Liposomes: State of the Art. Journal of Colloid Science and Biotechnology, 2012. 1(2): p. 147-168.
16. Liu, P., G. Chen, and J. Zhang, A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules, 2022. 27(4).
17. Elsharkasy, O.M., et al., Extracellular vesicles as drug delivery systems: Why and how? Advanced Drug Delivery Reviews, 2020. 159: p. 332-343.
18. Ju, S., et al., Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis. Molecular Therapy, 2013. 21(7): p. 1345-1357.
19. Zhuang, X., et al., Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain. Molecular Therapy, 2011. 19(10): p. 1769-1779.
20. Shafei, S., et al., Exosome loaded alginate hydrogel promotes tissue regeneration in full-thickness skin wounds: An in vivo study. J Biomed Mater Res A, 2020. 108(3): p. 545-556.
21. Tan, S.S., et al., Therapeutic MSC exosomes are derived from lipid raft microdomains in the plasma membrane. J Extracell Vesicles, 2013. 2.
22. Iwai, S., et al., Impact of ex vivo administration of mesenchymal stem cells on the function of kidney grafts from cardiac death donors in rat. Transplant Proc, 2014. 46(5): p. 1578-84.
23. Furuta, T., et al., Mesenchymal Stem Cell-Derived Exosomes Promote Fracture Healing in a Mouse Model. Stem Cells Transl Med, 2016. 5(12): p. 1620-1630.
24. Guo, S.X., et al., Beneficial effects of hydrogen-rich saline on early burn-wound progression in rats. PLoS One, 2015. 10(4): p. e0124897.
25. Li, X., et al., Exosome Derived From Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-induced Excessive Inflammation. EBioMedicine, 2016. 8: p. 72-82.
26. Zhao, B., et al., Exosomes derived from human amniotic epithelial cells accelerate wound healing and inhibit scar formation. J Mol Histol, 2017. 48(2): p. 121-132.
27. Jing, H., X. He, and J. Zheng, Exosomes and regenerative medicine: state of the art and perspectives. Transl Res, 2018. 196: p. 1-16.
28. Sun, S., et al., Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN. Life Sci, 2020. 244: p. 117297.
29. Hannafon, B.N., et al., Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res, 2016. 18(1): p. 90.
30. Tian, Y., et al., Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry. ACS Nano, 2018. 12(1): p. 671-680.
31. Zhou, B., et al., Application of exosomes as liquid biopsy in clinical diagnosis. Signal Transduct Target Ther, 2020. 5(1): p. 144.
32. Müller Bark, J., et al., Exosomes in cancer. 2021. p. 1-40.
33. Raimondo, S., et al., Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Communication and Signaling, 2015. 13(1).
34. Li, C., CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. World Journal of Gastroenterology, 2015. 21(20).
35. Ramteke, A., et al., Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Molecular Carcinogenesis, 2015. 54(7): p. 554-565.
36. Ahmad, A., et al., Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin. PLoS ONE, 2014. 9(2).
37. Takahashi, K., et al., Extracellular vesicle‐mediated transfer of long non‐coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio, 2014. 4(1): p. 458-467.
38. Kong, J.N., et al., Guggulsterone and bexarotene induce secretion of exosome‐associated breast cancer resistance protein and reduce doxorubicin resistance in MDA‐MB‐231 cells. International Journal of Cancer, 2015. 137(7): p. 1610-1620.
39. Tai, Y.L., et al., Exosomes in cancer development and clinical applications. Cancer Sci, 2018. 109(8): p. 2364-2374.
40. Chen, J., et al., Review on Strategies and Technologies for Exosome Isolation and Purification. Front Bioeng Biotechnol, 2021. 9: p. 811971.
41. Cocozza, F., et al., SnapShot: Extracellular Vesicles. Cell, 2020. 182(1): p. 262-262 e1.
42. Cvjetkovic, A., J. Lotvall, and C. Lasser, The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles. J Extracell Vesicles, 2014. 3.
43. Yang, X.X., et al., New insight into isolation, identification techniques and medical applications of exosomes. J Control Release, 2019. 308: p. 119-129.
44. Cantin, R., et al., Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods, 2008. 338(1-2): p. 21-30.
45. Zeringer, E., et al., Strategies for isolation of exosomes. Cold Spring Harb Protoc, 2015. 2015(4): p. 319-23.
46. Li, P., et al., Progress in Exosome Isolation Techniques. Theranostics, 2017. 7(3): p. 789-804.
47. Weng, Y., et al., Effective isolation of exosomes with polyethylene glycol from cell culture supernatant for in-depth proteome profiling. Analyst, 2016. 141(15): p. 4640-6.
48. Batrakova, E.V. and M.S. Kim, Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release, 2015. 219: p. 396-405.
49. Yang, D., et al., Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics, 2020. 10(8): p. 3684-3707.
50. Heinemann, M.L. and J. Vykoukal, Sequential Filtration: A Gentle Method for the Isolation of Functional Extracellular Vesicles. Methods Mol Biol, 2017. 1660: p. 33-41.
51. Dehghani, M., et al., Tangential flow microfluidics for the capture and release of nanoparticles and extracellular vesicles on conventional and ultrathin membranes. Adv Mater Technol, 2019. 4(11).
52. Heinemann, M.L., et al., Benchtop isolation and characterization of functional exosomes by sequential filtration. J Chromatogr A, 2014. 1371: p. 125-35.
53. Lebreton, B., A. Brown, and R. van Reis, Application of high-performance tangential flow filtration (HPTFF) to the purification of a human pharmaceutical antibody fragment expressed in Escherichia coli. Biotechnol Bioeng, 2008. 100(5): p. 964-74.
54. McNamara, R.P., et al., Large-scale, cross-flow based isolation of highly pure and endocytosis-competent extracellular vesicles. J Extracell Vesicles, 2018. 7(1): p. 1541396.
55. Busatto, S., et al., Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid. Cells, 2018. 7(12).
56. Liu, W.Z., Z.J. Ma, and X.W. Kang, Current status and outlook of advances in exosome isolation. Anal Bioanal Chem, 2022. 414(24): p. 7123-7141.
57. Brennan, K., et al., A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep, 2020. 10(1): p. 1039.
58. Morozumi, M., et al., Comparison of isolation methods using commercially available kits for obtaining extracellular vesicles from cow milk. J Dairy Sci, 2021. 104(6): p. 6463-6471.
59. Ingato, D., et al., Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery. J Control Release, 2016. 241: p. 174-185.
60. Greening, D.W., et al., A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol, 2015. 1295: p. 179-209.
61. Hartjes, T.A., et al., Extracellular Vesicle Quantification and Characterization: Common Methods and Emerging Approaches. Bioengineering (Basel), 2019. 6(1).
62. van der Pol, E., et al., Optical and non-optical methods for detection and characterization of microparticles and exosomes. J Thromb Haemost, 2010. 8(12): p. 2596-607.
63. Hueso, D., J. Fontecha, and P. Gomez-Cortes, Comparative study of the most commonly used methods for total protein determination in milk of different species and their ultrafiltration products. Front Nutr, 2022. 9: p. 925565.
64. Chen, L., et al., Quantitative evaluation of proteins with bicinchoninic acid (BCA): resonance Raman and surface-enhanced resonance Raman scattering-based methods. Analyst, 2012. 137(24): p. 5834-8.
65. Belhadj, Z., et al., A combined “eat me/don't eat me” strategy based on extracellular vesicles for anticancer nanomedicine. Journal of Extracellular Vesicles, 2020. 9(1).
66. Rana, S., et al., Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection. The International Journal of Biochemistry & Cell Biology, 2012. 44(9): p. 1574-1584.
67. Larios, J., et al., ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes. Journal of Cell Biology, 2020. 219(3).
68. Zhao, L., et al., Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis. Journal of Controlled Release, 2020. 318: p. 1-15.
69. Bergendahl, V., B.T. Glaser, and R.R. Burgess, A fast Western blot procedure improved for quantitative analysis by direct fluorescence labeling of primary antibodies. J Immunol Methods, 2003. 277(1-2): p. 117-25.
70. Alegria-Schaffer, A., A. Lodge, and K. Vattem, Performing and optimizing Western blots with an emphasis on chemiluminescent detection. Methods Enzymol, 2009. 463: p. 573-99.
71. Khan, M., et al., Enzyme-Linked Immunosorbent Assay versus Chemiluminescent Immunoassay: A General Overview. Global Journal of Medical, Pharmaceutical, and Biomedical Update, 2023. 18.
72. Adan, A., et al., Flow cytometry: basic principles and applications. Crit Rev Biotechnol, 2017. 37(2): p. 163-176.
73. Mukherjee, P.K., R.K. Harwansh, and S. Bhattacharyya, Bioavailability of Herbal Products, in Evidence-Based Validation of Herbal Medicine. 2015. p. 217-245.
74. Badwaik, H.R., et al., Phytoconstituent plumbagin: Chemical, biotechnological and pharmaceutical aspects, in Bioactive Natural Products. 2019. p. 415-460.
75. Su, Y., et al., PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Deliv, 2021. 28(1): p. 1397-1418.
76. Nguyen, D.N., C. Clasen, and G. Van den Mooter, Pharmaceutical Applications of Electrospraying. J Pharm Sci, 2016. 105(9): p. 2601-2620.
77. Morais, A.I.S., et al., Fabrication of Polymeric Microparticles by Electrospray: The Impact of Experimental Parameters. J Funct Biomater, 2020. 11(1).
78. Deshmukh, R., P. Wagh, and J. Naik, Solvent evaporation and spray drying technique for micro- and nanospheres/particles preparation: A review. Drying Technology, 2016. 34(15): p. 1758-1772.
79. Koerner, J., D. Horvath, and M. Groettrup, Harnessing Dendritic Cells for Poly (D,L-lactide-co-glycolide) Microspheres (PLGA MS)-Mediated Anti-tumor Therapy. Front Immunol, 2019. 10: p. 707.
80. Freitas, S., H.P. Merkle, and B. Gander, Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release, 2005. 102(2): p. 313-32.
81. Čulo, I., et al., Emulsification on a Microscale: Faster, Better, and More Effective. Kemija u industriji, 2022(9-10).
82. Ashlee D. Brunaugh, H.D.C.S.R.O.W.I., Disperse Systems: Emulsions. AAPS, 2019.
83. Van Tomme, S.R., G. Storm, and W.E. Hennink, In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm, 2008. 355(1-2): p. 1-18.
84. Spagnoli, C., et al., Hyaluronan conformations on surfaces: effect of surface charge and hydrophobicity. Carbohydr Res, 2005. 340(5): p. 929-41.
85. Rinaudo, M., Chitin and chitosan: Properties and applications. Progress in Polymer Science, 2006. 31(7): p. 603-632.
86. Aubin, H., et al., Directed 3D cell alignment and elongation in microengineered hydrogels. Biomaterials, 2010. 31(27): p. 6941-6951.
87. Drury, J.L. and D.J. Mooney, Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials, 2003. 24(24): p. 4337-51.
88. Martin, B.C., et al., Agarose and methylcellulose hydrogel blends for nerve regeneration applications. J Neural Eng, 2008. 5(2): p. 221-31.
89. Awad, H.A., et al., Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 2004. 25(16): p. 3211-22.
90. Yamada, Y., et al., Laminin active peptide/agarose matrices as multifunctional biomaterials for tissue engineering. Biomaterials, 2012. 33(16): p. 4118-25.
91. Jiang, F., et al., Extraction, Modification and Biomedical Application of Agarose Hydrogels: A Review. Mar Drugs, 2023. 21(5).
92. HJERTkN., S., B.-L. WU.., and J.-L. LIAO., AN HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC MATRIX
BASED ON AGAROSE CROSS-LINKED WITH DIVINYL SULPHONE Journal of Chromatography, 1987. 396: p. 101-113.
93. Zhao, X., et al., Fabrication of rigid and macroporous agarose microspheres by pre-cross-linking and surfactant micelles swelling method. Colloids Surf B Biointerfaces, 2019. 182: p. 110377.
94. Xiao, Q., et al., Gel properties transition from mono-succinylation to cross-linking of agar by attemperation with succinic anhydride. Food Chem, 2022. 381: p. 132164.
95. Trombino, S., et al., Green Chemistry Principles for Nano- and Micro-Sized Hydrogel Synthesis. Molecules, 2023. 28(5).
96. Bao, J., et al., Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization. Sci Rep, 2015. 5: p. 10756.
97. Sakiyama-Elbert, S.E., Incorporation of heparin into biomaterials. Acta Biomater, 2014. 10(4): p. 1581-7.
98. Duo, J. and J.A. Stenken, Heparin-immobilized microspheres for the capture of cytokines. Anal Bioanal Chem, 2011. 399(2): p. 773-82.
99. Banik, N., et al., Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules. Int J Mol Sci, 2021. 22(19).
100. Geno J. Merli, M., and James B. Groce, PharmD, Pharmacological and Clinical Differences Between Low-Molecular-Weight Heparins. Pharmacy and Therapeutics, 2009. 35.
101. Lee, M.S. and J. Kong, Heparin: Physiology, Pharmacology, and Clinical Application. Rev Cardiovasc Med, 2015. 16(3): p. 189-99.
102. Rabenstein, D.L., Heparin and heparan sulfate: structure and function. Nat Prod Rep, 2002. 19(3): p. 312-31.
103. Heyligers, J.M., et al., Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg, 2006. 43(3): p. 587-91.
104. Keuren, J.F., et al., Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol, 2004. 24(3): p. 613-7.
105. Kanzaki, S., et al., Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J Cell Physiol, 2008. 216(3): p. 844-50.
106. Willerth, S.M., A. Rader, and S.E. Sakiyama-Elbert, The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res, 2008. 1(3): p. 205-18.
107. Lam, H.J., et al., In vitro regulation of neural differentiation and axon growth by growth factors and bioactive nanofibers. Tissue Eng Part A, 2010. 16(8): p. 2641-8.
108. Chang, C.W., et al., Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells. Biomaterials, 2013. 34(4): p. 912-21.
109. Yin, J., et al., Boronic acid-functionalized agarose affinitychromatography for isolation of tropomyosinin fishes. J Sci Food Agric, 2019. 99(14): p. 6490-6499.
110. SUNDBERG, L. and J. PORATH, PREPARATION OF ADSORBENTS FOR BIOSPECIFIC AFFINITY CHROMATOGRAPHY. Chromatography, 1974.
111. Skop, N.B., et al., Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair. Acta Biomater, 2013. 9(6): p. 6834-43.
112. Li, Z., et al., Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. Acta Biomater, 2015. 13: p. 88-100.
113. Gumusderelioglu, M. and S. Aday, Heparin-functionalized chitosan scaffolds for bone tissue engineering. Carbohydr Res, 2011. 346(5): p. 606-13.
114. Barnes, B., et al., Investigating heparin affinity chromatography for extracellular vesicle purification and fractionation. J Chromatogr A, 2022. 1670: p. 462987.
115. Leach, J.B., et al., Crosslinked alpha-elastin biomaterials: towards a processable elastin mimetic scaffold. Acta Biomater, 2005. 1(2): p. 155-64.
116. Mantri, V.A., et al., Limited-scale field trial confirmed differences in growth and agarose characteristics in life-cycle stages of industrially important marine red alga Gracilaria dura (Gracilariales, Rhodophyta). Journal of Applied Phycology, 2021. 33(2): p. 1059-1070.
117. Zarei, Z. and B. Akhlaghinia, Ce(III) immobilised on aminated epichlorohydrin-activated agarose matrix – “green” and efficient catalyst for transamidation of carboxamides. Chemical Papers, 2015. 69(11).
118. T. Lopez, et al., Thermal Characterization of Agar Encapsulated in TiO2 Sol–Gel. Journal of Thermophysics, 2004.
119. Fu, J., Z. Cao, and L. Yobas, Localized oblique-angle deposition: Ag nanorods on microstructured surfaces and their SERS characteristics. Nanotechnology, 2011. 22(50): p. 505302.
120. Eshaghi, A. and M. Salehi, Fabrication and characterization of optical, mechanical and chemical properties of diamond-like carbon thin film deposited on polymer substrate. Optical and Quantum Electronics, 2018. 50(12).
121. Andrgie, A.T., et al., Ibuprofen-Loaded Heparin Modified Thermosensitive Hydrogel for Inhibiting Excessive Inflammation and Promoting Wound Healing. Polymers (Basel), 2020. 12(11).
122. Zuo, Q., et al., Heparin-conjugated alginate multilayered microspheres for controlled release of bFGF. Biomed Mater, 2015. 10(3): p. 035008.
123. Miller, G.J., et al., Synthesis of a heparin-related GlcN-IdoA sulfation-site variable disaccharide library and analysis by Raman and ROA spectroscopy. Carbohydr Res, 2014. 400: p. 44-53.
124. S, E.L.A., et al., Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov, 2013. 12(5): p. 347-57.
125. Li, K.L., et al., Role of exosomes in the pathogenesis of inflammation in Parkinson's disease. Neural Regen Res, 2022. 17(9): p. 1898-1906.
126. Atai, N.A., et al., Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol, 2013. 115(3): p. 343-51.